Beyond Weight Loss at The Longevity Show in London

About this video

This short panel clip from the Longevity Show in London has non-English (Arabic) captions, so the summary is based on what can be read from those captions. In them, Yurth argues GLP-1 medicines themselves do not cause muscle loss. She contends DEXA scans can mislead when fat stored within muscle is lost, making muscle look smaller while, she claims, its quality and metabolic function improve and strength measures can rise. In her account, people who do lose strength on these medicines are usually eating too little protein and not training enough, and rapid weight loss driven by under-nutrition is the problem to correct, not the drug class itself.

Key takeaways

• Title-only context plus captions frame the debate as muscle quality versus muscle size on scans
• Do not blame a medicine for loss that, Yurth argues, tracks with low protein and inactivity
• Interpret body-composition scans in context when fat inside muscle is changing
• Prioritize protein intake and resistance training during any weight-loss treatment

Episode details: published July 4, 2026 · 242 views · 1:20 long. Summary written by Self Growth Videos from the episode itself. The longevity and peptide concepts described are Dr. Elizabeth Yurth’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Dr. Yurth is co-founder and Chief Medical Officer of the Boulder Longevity Institute, a clinic, and BLI Academy sells clinician education.

← Previous: My Healthspan Routine · Next: NAD Is Not Something You Just Dump Into the Body →

All Dr. Elizabeth Yurth videos · Dr. Elizabeth Yurth profile · Boulder Longevity Institute (official site)